delcasertib
Peptideexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00093197)
Timeline
Indications
Mechanism of action
- Protein kinase C deltaINHIBITOR
PRKCD inhibitor
- Protein kinase C alphaINHIBITOR
PRKCA inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107872 ↗
Also known as
- bms-875944
- bms-875944
- delcasertib
- delcasertib
- delcasertib
- kai9803
- kai 9803
- kai-9803
- kai-9803
- kai-9803
- kai-9803
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00785954 | Phase 2 | Nov 1, 2008 | Bristol-Myers Squibb, Duke University, KAI Pharmaceuticals, University of Rochester |
| NCT00093197 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2004 | KAI Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| KAI Pharmaceuticals | For profit | 2 | 2 | 1 | 2004 |
| Bristol-Myers Squibb | For profit | 1 | 0 | 1 | 2008 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1